Hyaluronic Acid-Modified Cationic Nanoparticles Overcome Enzyme CYP1B1-Mediated Breast Cancer Multidrug Resistance

References

• Desantis CE , FedewaSA, Goding SauerA, KramerJL, SmithRA, JemalA. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J. Clin.66 (1), 31–42 (2016).
   PubMed Web of Science ®Google Scholar
• Xia C , KahnC, WangJ, LiaoY, ChenW, YuXQ. Temporal trends in geographical variation in breast cancer mortality in China, 1973–2005: an analysis of nationwide surveys on cause of death. Int. J. Env. Res. Public Health13 (10), 963 (2016).
   PubMed Web of Science ®Google Scholar
• Jin Y , ZhangW, WangHet al. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo. Oncol. Rep.35 (2), 771–778 (2016).
   PubMed Web of Science ®Google Scholar
• Tang Y , SoroushF, TongZ, KianiMF, WangB. Targeted multidrug delivery system to overcome chemoresistance in breast cancer. Int. J. Nanomed.12, 671 (2017).
   PubMed Web of Science ®Google Scholar
• Iuliis FD , SalernoG, TaglieriL, ScarpaS. Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review. Cancer Chemother. Pharmacol.76 (4), 679–690 (2015).
   PubMed Web of Science ®Google Scholar
• Mcfadyen MC , MelvinWT, MurrayGI. Cytochrome p450 enzymes: novel options for cancer therapeutics. Mol. Cancer Ther.3 (3), 363–371 (2004).
   PubMed Web of Science ®Google Scholar
• Bach DH , HongJY, ParkHJ, LeeSK. The role of exosomes and miRNAs in drug-resistance of cancer cells. Int. J. Cancer, 141 (2), 220–230 (2017).
   PubMed Web of Science ®Google Scholar
• Garajová I , LeLT, GiovannettiE, KazemierG, BiascoG, PetersGJ. The role of microRNAs in resistance to current pancreatic cancer treatment: translational studies and basic protocols for extraction and PCR analysis. In : Cancer Drug Resistance. JoseRueff, António SebastiãoRodrigues ( Eds). Springer, NY, USA (2016).
   Google Scholar
• Motaghed M , AlhassanFM, HamidSS. Thymoquinone regulates gene expression levels in the estrogen metabolic and interferon pathways in MCF7 breast cancer cells. Int. J. Mol. Med.33 (1), 8–16 (2014).
   PubMed Web of Science ®Google Scholar
• Patterson LH , MurrayGI. Tumour cytochrome p450 and drug activation. Curr. Pharm. Des.8 (15), 1335–1347 (2002).
   PubMed Web of Science ®Google Scholar
• Monroig PDC , CalinGA. Drug–MicroRNA Cross-Talk. In : ChandanK. Sen ( Ed.). MicroRNA in Regenerative Medicine. Academic Press, Salt Lake City, USA, 991–1016 (2015).
   Google Scholar
• Wen X , WalleT. Cytochrome p450 1B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer. Cancer Lett.246 (1-2), 109 (2007).
   PubMed Web of Science ®Google Scholar
• López JA , LópezAJG. MiRNAs in Cervical Cancer Radio- and Chemotherapy Response. In : Colposcopy and Cervical Pathology. RajamanickamRajkumar ( Ed.). IntechOpen, London, United Kingdom, 85–105 (2017).
   Google Scholar
• Li H , YangBB. Friend or foe: the role of microRNA in chemotherapy resistance. Acta Pharmacol. Sin.34 (7), 870–879 (2013).
   PubMed Web of Science ®Google Scholar
• Engels FK , SparreboomA, MathotRA, VerweijJ. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review. Br. J. Cancer93 (2), 173–177 (2005).
   PubMed Web of Science ®Google Scholar
• Mu W , HuC, ZhangHet al. miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression. Cell Res.25 (4), 477–495 (2015).
   PubMed Web of Science ®Google Scholar
• Cui J , MengQ, ZhangX, CuiQ, ZhouW, LiS. Design and synthesis of new α-naphthoflavones as cytochrome p450 (CYP) 1B1 inhibitors to overcome docetaxel-resistance associated with CYP1B1 overexpression. J. Med. Chem.58 (8), 3534–3547 (2015).
   PubMed Web of Science ®Google Scholar
• Cui J , LiS. Structure, chemistry and pharmacology of naphthoflavones. Mini. Rev. Med. Chem.13 (9), 1357–1368 (2013).
   PubMed Web of Science ®Google Scholar
• Gullapalli RP , MazzitelliCL. Polyethylene glycols in oral and parenteral formulations: a critical review. Int. J. Pharm.496 (2), 219–239 (2015).
   PubMedGoogle Scholar
• Qiu L , LiZ, QiaoMet al. Self-assembled pH-responsive hyaluronic acid–g-poly(l-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin. Acta Biomater.10 (5), 2024–2035 (2014).
   PubMed Web of Science ®Google Scholar
• Li J , ZhangJ, WangYet al. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway. Int. J. Pharm.523 (1), 300–309 (2017).
   PubMed Web of Science ®Google Scholar
• Wang G , MacielD, WuYet al. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery. ACS Appl. Mater. Interfaces6 (19), 16687–16695 (2014).
   PubMed Web of Science ®Google Scholar
• Fang C , WangK, StephenZRet al. Temozolomide nanoparticles for targeted glioblastoma therapy. ACS Appl. Mater. Interfaces7 (12), 6674–6682 (2015).
   PubMed Web of Science ®Google Scholar
• Godinho BM , OgierJR, QuinlanAet al. PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability. Int. J. Pharm.473 (1–2), 105–112 (2014).
   PubMedGoogle Scholar
• Jacob A , HartzAM, PotinSet al. Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels. Fluids Barriers CNS8 (1), 23 (2011).
   PubMedGoogle Scholar
• Mahringer A , FrickerG. ABC transporters at the blood–brain barrier. Expert Opin. Drug Metab. Toxicol.12 (5), 499 (2013).
   Google Scholar
• Tang H , ZengL, WangJet al. Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer. Oncotarget8 (47), 82842–82853 (2017).
   PubMedGoogle Scholar
• Tian W , LiuJ, GuoY, ShenY, ZhouD, GuoS. Self-assembled micelles of amphiphilic PEGylated rapamycin for loading paclitaxel and resisting multidrug resistant cancer cells. J. Mater. Chem. B Mater. Biol. Med.3 (7), 1204–1207 (2015).
   PubMed Web of Science ®Google Scholar
• Rafiei P , HaddadiA. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int. J. Nanomed.12, 935–947 (2017).
   PubMed Web of Science ®Google Scholar
• Wang Y , WangF, LiuYet al. Glutathione detonated and pH-responsive nano-clusters of Au nanorods with a high dose of DOX for treatment of multidrug-resistant cancer. Acta Biomater.75, 334–345 (2018).
   PubMed Web of Science ®Google Scholar
• Wu Y , WangK, TanH, XuJ, ZhuJ. Emulsion solvent evaporation-induced self-assembly of block copolymers containing pH-sensitive block. Langmuir33 (38), 9889–9896 (2017).
   PubMed Web of Science ®Google Scholar
• Zhao Q , LiuJ, ZhuWet al. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta Biomater.23, 147–156 (2015).
   PubMed Web of Science ®Google Scholar
• Vieira SM , MichelsLR, RoversiKet al. A surface modification of clozapine-loaded nanocapsules improves their efficacy: a study of formulation development and biological assessment. Colloids Surf. B. Biointerfaces145, 748–756 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang W , SongY, EldiPet al. Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles. Int. J. Nanomed.   13, 293–305 (2018).
   PubMed Web of Science ®Google Scholar
• Lim SM , PangZW, TanHY, ShaikhM, AdinarayanaG, GargS. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems. Drug Dev. Ind. Pharm.41 (11), 1847–1855 (2015).
   PubMed Web of Science ®Google Scholar
• Chen J , QiuL, HuM, JinY, HanJ. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel. Drug Dev. Ind. Pharm.34 (6), 588–594 (2008).
   PubMed Web of Science ®Google Scholar
• Engels FK , MathotRAA, VerweijJ. Alternative drug formulations of docetaxel: a review. Anticancer Drugs18 (2), 95–103 (2007).
   PubMed Web of Science ®Google Scholar
• Hu K , FengJ, CaoS. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int. J. Nanomed. doi: 10.2147/ijn.s328803537 (2012) ( Epub ahead of print).
   Google Scholar
• Lee SG , KimCH, SungSWet al. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells. Int. J. Nanomed.13, 3263–3278 (2018).
   PubMed Web of Science ®Google Scholar
• Xu Y , WangC, DingYet al. Nanoparticles with optimal ratiometric co-delivery of docetaxel with gambogic acid for treatment of multidrug-resistant breast cancer. J. Biomed. Nanotechnol.12 (9), 1774–1781 (2016).
   PubMed Web of Science ®Google Scholar
• Zhu Z , MuY, QiCet al. CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro . Int. J. Mol. Med. 35 (2), 340–348 (2015).
   PubMed Web of Science ®Google Scholar
• Zhong Y , GoltscheK, ChengLet al. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Biomaterials84, 250–261 (2016).
   PubMed Web of Science ®Google Scholar
• Wu M , MengQ, ChenYet al. Large-pore ultrasmall mesoporous organosilica nanoparticles: micelle/precursor co-templating assembly and nuclear-targeted gene delivery. Adv. Mater.27 (2), 215–222 (2015).
   PubMed Web of Science ®Google Scholar
• Xiao J , DuanX, YinQ, ChenL, ZhangZ, LiY. Low molecular weight polyethylenimine-graft-Tween 85 for effective gene delivery: synthesis and in vitro characteristics. Bioconjug. Chem.23 (2), 222–231 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang L , YuM, WangJet al. Low molecular weight PEI-based vectors via acid-labile ortho ester linkage for improved gene delivery. Macromol. Biosci.16 (8), 1175–1187 (2016).
   PubMed Web of Science ®Google Scholar
• Essex S , NavarroG, SabhachandaniPet al. Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors. Gene Ther.22 (3), 257–266 (2015).
   PubMed Web of Science ®Google Scholar
• Lauschke VM , BarraganI, Ingelman-SundbergM. Pharmacoepigenetics and toxicoepigenetics: novel mechanistic insights and therapeutic opportunities. Annu. Rev. Pharmacol. Toxicol.58 (1), (2017).
   Google Scholar
• Feng LX , LiM, LiuYJ, YangSM, ZhangN. Synergistic enhancement of cancer therapy using a combination of ceramide and docetaxel. Int. J. Mol. Sci.15 (3), 4201–4220 (2014).
   PubMed Web of Science ®Google Scholar
• Mediavilla-Varela M , PachecoFJ, AlmaguelFet al. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol. Cancer8 (1), 68 (2009).
   PubMedGoogle Scholar
• Gao X , ZhangJ, HuangZet al. Reducing interstitial fluid pressure and inhibiting pulmonary metastasis of breast cancer by gelatin-modified cationic lipid nanoparticles. ACS Appl. Mater. Interfaces9 (35), 29457–29468 (2017).
   PubMed Web of Science ®Google Scholar
• Zhu X , XuY, SolisLMet al. Long-circulating siRNA nanoparticles for validating prohibitin1-targeted non-small-cell lung cancer treatment. Proc. Natl Acad. Sci. USA112 (25), 7779–7784 (2015).
   PubMed Web of Science ®Google Scholar
• Zhou Z , LiuY, WuL, LiL, HuangY. Enhanced nuclear delivery of anti-cancer drugs using micelles containing releasable membrane fusion peptide and nuclear-targeting retinoic acid. J. Mater. Chem. B5 (34), 7175–7185 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang G , YangM, CaiDet al. Composite of functional mesoporous silica and DNA: an enzyme-responsive controlled release drug carrier system. ACS Appl. Mater. Interfaces6 (11), 8042–8047 (2014).
   PubMed Web of Science ®Google Scholar
• Klauber TC , SondergaardRV, SawantRR, TorchilinVP, AndresenTL. Elucidating the role of free polycations in gene knockdown by siRNA polyplexes. Acta Biomater.35, 248–259 (2016).
   PubMed Web of Science ®Google Scholar
• Lee WS , KimYK, ZhangQet al. Polyxylitol-based gene carrier improves the efficiency of gene transfer through enhanced endosomal osmolysis. Nanomedicine10 (3), 525–534 (2014).
   PubMed Web of Science ®Google Scholar
• Ku SH , KimK, ChoiK, KimSH, KwonIC. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy. Adv. Healthc. Mater.3 (8), 1182–1193 (2015).
   Web of Science ®Google Scholar
• Luo D , CarterKA, RaziAet al. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Biomaterials75, 193–202 (2016).
   PubMed Web of Science ®Google Scholar
• Xie L , WangG, ZhouHet al. Functional long circulating single walled carbon nanotubes for fluorescent/photoacoustic imaging-guided enhanced phototherapy. Biomaterials103, 219–228 (2016).
   PubMed Web of Science ®Google Scholar